Novo Nordisk

Novo Nordisk Seeks US Court Order to Halt Eli Lillys Weight-Loss Drug Ads

Novo Nordisk Seeks US Court Order to Halt Eli Lilly's Weight-Loss Drug Ads

BY Outlook Business Desk

novo nordisk

Novo Nordisk Sues Eli Lilly; Alleges Misleading Weight-Loss Drug Advertising

BY Outlook Business Desk

Novo Nordisk Gets CDSCO Nod for Indication of Wegovy in Fatty Liver Treatment

Novo Nordisk Gets CDSCO Nod for Indication of Wegovy in Fatty Liver Treatment

BY PTI

novo nordisk : Novo Nordisk

Novo Nordisk Turns to AI, India to Speed Drug Launches

BY Outlook Business Desk

A Weight-Loss Shot for Alcohol Addiction? What New Data Reveals

A Weight-Loss Shot for Alcohol Addiction? What New Data Reveals

BY Outlook Business Desk

Inside the Scramble for India’s Post-Patent Semaglutide Market

One Goal, 50 Brands: Inside the Scramble for India’s Post-Patent Semaglutide Market

BY Shashank Bhatt

Novo Nordisk

Novo Nordisk Cuts Ozempic, Wegovy Prices by Up to 48% Amid Generic Pressure

BY Outlook Business Desk

Advertisement

Nova Nordisks

Indian Pharma Lines Up for Ozempic-Like Weight-Loss Drugs

BY Outlook Business Desk

Sun Pharma Gets DCGI Nod For Generic Weight-Loss Drug Amid Patent Fight With Novo Nordisk

Sun Pharma Gets DCGI Nod For Generic Weight-Loss Drug

BY Outlook Business Desk

Danish Novo Holdings Acquires 49% Stake in Pune’s Surya Hospitals

Novo Holdings Acquires 49% Stake in Surya Hospitals

BY Outlook Business Desk

Shutterstock

Natco Challenges Novo Nordisk’s Semaglutide Patent

BY Outlook Business Desk

Novo Nordisk

Novo Nordisk Rolls Out Ozempic in India

BY Outlook Business Desk

Dr Reddys

Delhi HC Allows Dr Reddy’s to Export Weight-Loss Drug

BY Outlook Business Desk